The price of Stelara 45 mg can vary significantly depending on several factors, including the pharmacy, insurance coverage, and whether it is a branded or generic version.
How much does a Stelara prescription typically cost?
A single 45 mg vial of Stelara can range from approximately $5,000 to over $7,000 in the United States [1]. This cost reflects the drug's status as a biologic medication used to treat chronic inflammatory conditions such as plaque psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis.
What influences the price of Stelara?
The price of Stelara is influenced by its complex manufacturing process as a biologic, the research and development costs incurred by the manufacturer, and market demand [2]. Insurance plans also play a crucial role; co-pays can range from a few dollars to hundreds of dollars per dose, depending on the specific plan and deductible status. Patients without insurance may face the full retail price, though manufacturer assistance programs might be available.
When does Stelara patent protection expire?
Stelara's primary patents were set to expire in the late 2020s, with some expiring as early as 2023 [3]. This timeline is critical for the potential introduction of biosimilar versions. DrugPatentWatch.com tracks these patent expirations, which can significantly impact pricing dynamics [3].
Can biosimilars reduce Stelara's cost?
The introduction of biosimilar versions of Stelara is expected to increase competition and potentially lower prices for patients and healthcare systems. Biosimilars are highly similar to their reference biologic products, offering comparable safety and efficacy but often at a reduced cost [2]. However, the exact timing and impact of biosimilar availability on pricing depend on regulatory approvals and market uptake.
How can patients afford Stelara?
Patients seeking to manage the cost of Stelara may explore several avenues. Manufacturer co-pay assistance programs can help eligible individuals reduce out-of-pocket expenses [1]. Comparing prices at different pharmacies and consulting with insurance providers about coverage options are also recommended steps. For those without insurance, exploring patient assistance foundations or discount cards might provide some relief.
Sources:
1. GoodRx
2. FDA
3. DrugPatentWatch.com